Patent ID: 7989620
Filing Date: 2011-08-02
Classification: A61P,C07D

Abstract:
1. A compound selected from the group consisting of: (5S)-5-methyl-5-({[4-{[2-(methylthio)pyrimidin-5 -yl]ethynyl}-3,6-dihydropyridin-1(2H) -yl]sulfonyl}methyl)imidazolidine-2,4-dione; (5S)-5-methyl-5-({[4-{[2-(trifluoromethyl)pyrimidin -5-yl]ethynyl}-3,6-dihydropyridin-1(2H) -yl]sulfonyl}methyl)imidazolidine-2,4-dione; (5S)-5-methyl-5-({[4-[(2-methylpyrimidin-5-yl)ethynyl]-3,6-dihydropyridin-1(2H) -yl]sulfonyl}methyl)imidazolidine-2,4-dione; (5S)-5-({[4-[(2-ethylpyrimidin-5-yl)ethynyl]-3,6-dihydropyridin-1(2H)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; and (5S)-5-({[4-[(2-methoxypyrimidin-5-yl)ethynyl]-3,6-dihydropyridin-1(2H)-yl]sulfonyl}methyl) -5-methylimidazolidine-2,4-dione; and pharmaceutically acceptable salts thereof.